Traditionally, drug discovery has focused on small molecules, but peptidic partners are progressively demonstrating attention. This new approach utilizes combining short amino acid chains with alternative therapeutic methods to confront complex illness targets. By employing the unique properties of amino acid sequences – such as significant speci